Stock QNRX QUOIN PHARMACEUTICALS, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Quoin Pharmaceuticals, Ltd.

Equities

QNRX

US74907L3006

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-06-21 EDT 		5-day change 1st Jan Change
0.6124 USD -1.84% Intraday chart for Quoin Pharmaceuticals, Ltd. -10.75% -87.51%
06-06 Certain Options of Quoin Pharmaceuticals, Ltd. are subject to a Lock-Up Agreement Ending on 6-JUN-2024. CI
06-06 Certain Warrants of Quoin Pharmaceuticals, Ltd. are subject to a Lock-Up Agreement Ending on 6-JUN-2024. CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 15.19 6.884 4.842 2.437 - -
Enterprise Value (EV) 1 15.19 6.884 4.842 2.437 2.437 2.437
P/E ratio -0.34 x -0.36 x -0.51 x -0.17 x -0.65 x -2.72 x
Yield - - - - - -
Capitalization / Revenue - - - - - 0.25 x
EV / Revenue - - - - - 0.25 x
EV / EBITDA - - - - - -
EV / FCF -3,281,594 x - - - - -
FCF Yield -0% - - - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) 55.7 404 987 3,980 - -
Reference price 2 273.0 17.04 4.905 0.6124 0.6124 0.6124
Announcement Date 22-04-14 23-03-09 24-03-13 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - - - - - - 9.596
EBITDA - - - - - - -
EBIT 1 - -6.063 -9.258 -9.378 -10.12 -11.24 -9.874
Operating Margin - - - - - - -102.9%
Earnings before Tax (EBT) 1 - -21.46 -9.382 -8.687 -10.46 -11.16 -7.718
Net income 1 -2.095 -21.46 -9.447 -8.687 -7.979 -11.16 -7.718
Net margin - - - - - - -80.43%
EPS 2 -315.0 -813.0 -46.80 -9.640 -3.515 -0.9350 -0.2250
Free Cash Flow - -4.63 - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 21-06-16 22-04-14 23-03-09 24-03-13 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - - - - - - - - - - - - -
EBITDA - - - - - - - - - - - - -
EBIT 1 -2.981 -2.176 -2.668 -2.328 -2.086 -2.776 -2.26 -2.125 -2.218 - -2.513 -2.563 -2.59
Operating Margin - - - - - - - - - - - - -
Earnings before Tax (EBT) 1 -11.82 -1.683 -2.668 -3.03 -2.001 -2.603 -2.107 -1.927 -2.05 - -2.581 -2.71 -2.846
Net income 1 -11.82 -1.683 -2.668 -3.095 -2.001 -2.603 -2.107 -1.927 -2.05 - -2.455 -2.515 -2.566
Net margin - - - - - - - - - - - - -
EPS 2 634.5 -30.00 -38.88 -11.28 -4.955 -4.080 -2.130 -1.950 -2.080 - -0.7150 -0.6350 -0.6500
Dividend per Share - - - - - - - - - - - - -
Announcement Date 22-04-14 22-05-23 22-08-18 22-11-10 23-03-09 23-05-09 23-08-03 23-11-09 24-03-13 24-05-09 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - -4.63 - - - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - - - - - - -
Capex / Sales - - - - - - -
Announcement Date 21-06-16 22-04-14 23-03-09 24-03-13 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.6124 USD
Average target price
5.483 USD
Spread / Average Target
+795.38%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
QUOIN PHARMACEUTICALS, LTD. Stock Quoin Pharmaceuticals, Ltd.
-87.51% 2.44M
MODERNA, INC. Stock Moderna, Inc.
+34.14% 51.12B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-6.54% 39.4B
LONZA GROUP AG Stock Lonza Group AG
+34.92% 38.48B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+12.62% 26.36B
CELLTRION, INC. Stock Celltrion, Inc.
-12.11% 26.22B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-13.43% 20.96B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+43.73% 14.02B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+31.81% 12.49B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-4.54% 11.61B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. QNRX Stock
  4. Financials Quoin Pharmaceuticals, Ltd.